Skip to main content

Find Clinical Trials

Home
Conditions
Hormone-Refractory Prostate Cancer

Clinical trial condition

Hormone-Refractory Prostate Cancer

Explore clinical trials studying Hormone-Refractory Prostate Cancer. Study availability and eligibility vary by location and protocol.

15 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Hormone-Refractory Prostate Cancer trial results

Completed

Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

NCT01422850

Conditions: Hormone-Refractory Prostate Cancer
Locations: Department of Urology Frederikssund, Denmark

View Trial Details

Completed

Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

NCT00891345

Conditions: Hormone-Refractory Prostate Cancer
Locations: Urological Clinic, Frederikssunds Hospital Frederikssund, Denmark

View Trial Details

Completed

A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients

NCT00675545

Conditions: Hormone-Refractory Prostate Cancer
Locations: National University Hospital Singapore

View Trial Details

Completed

Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer

NCT01133704

Conditions: Hormone-Refractory Prostate Cancer
Locations: Not specified

View Trial Details

Completed

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients

NCT00636740

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Birmingham Hematology & Oncology Associates, LLC Birmingham, Alabama, United States

Cancer Care of North Florida, P.A. Lake City, Florida, United States

Lakeland Regional Cancer Center Lakeland, Florida, United States

Innovative Medical Research of South Florida, Inc. Miami, Florida, United States

View all 13 locations

View Trial Details